Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Journal of the American Chemical Society
|
February 5, 2004
Scope of palladium-catalyzed alkylative ring opening
Mark Lautens, Sheldon Hiebert
Accounts of Chemical Research
|
January 22, 2003
Transition metal-catalyzed enantioselective ring-opening reactions of oxabicyclic alkenes
Mark Lautens, Keith Fagnou, Sheldon Hiebert
Organic Letters
|
February 25, 2005
Toward an enantioselective total synthesis of sarain A: construction of an advanced intermediate and rearrangement of the sarain A core under mild conditions
Christopher J Douglas, Sheldon Hiebert, Larry E Overman
Organic Letters
|
May 25, 2002
Total synthesis of ionomycin using ring-opening strategies
Mark Lautens, John T Colucci, Sheldon Hiebert, et al.
The Journal of Organic Chemistry
|
September 25, 2007
Synthesis of all low-energy stereoisomers of the tris(pyrrolidinoindoline) alkaloid hodgkinsine and preliminary assessment of their antinociceptive activity
Jeremy J Kodanko, Sheldon Hiebert, Emily A Peterson, et al.
Journal of the American Chemical Society
|
September 14, 2007
Total synthesis of (+)-sarain A
Michael H Becker, Peter Chua, Robert Downham, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 23, 2017
The discovery and optimization of naphthalene-linked P2-P4 Macrocycles as inhibitors of HCV NS3 protease
Michael Bowsher, Sheldon Hiebert, Rongti Li, et al.
Chemmedchem
|
July 4, 2014
4-Benzothiazole-7-hydroxyindolinyl diaryl ureas are potent P2Y1 antagonists with favorable pharmacokinetics: low clearance and small volume of distribution
Jennifer X Qiao, Tammy C Wang, Sheldon Hiebert, et al.
Journal of Medicinal Chemistry
|
October 30, 2013
Conformationally constrained ortho-anilino diaryl ureas: discovery of 1-(2-(1'-neopentylspiro[indoline-3,4'-piperidine]-1-yl)phenyl)-3-(4-(trifluoromethoxy)phenyl)urea, a potent, selective, and bioavailable P2Y1 antagonist
Jennifer X Qiao, Tammy C Wang, Réjean Ruel, et al.
Journal of Medicinal Chemistry
|
November 23, 2020
Discovery of BMS-986144, a Third-Generation, Pan-Genotype NS3/4A Protease Inhibitor for the Treatment of Hepatitis C Virus Infection
Li-Qiang Sun, Eric Mull, Stanley D'Andrea, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Journal of the American Chemical Society
|
February 5, 2004
Scope of palladium-catalyzed alkylative ring opening
Mark Lautens, Sheldon Hiebert
Accounts of Chemical Research
|
January 22, 2003
Transition metal-catalyzed enantioselective ring-opening reactions of oxabicyclic alkenes
Mark Lautens, Keith Fagnou, Sheldon Hiebert
Organic Letters
|
February 25, 2005
Toward an enantioselective total synthesis of sarain A: construction of an advanced intermediate and rearrangement of the sarain A core under mild conditions
Christopher J Douglas, Sheldon Hiebert, Larry E Overman
Organic Letters
|
May 25, 2002
Total synthesis of ionomycin using ring-opening strategies
Mark Lautens, John T Colucci, Sheldon Hiebert, et al.
The Journal of Organic Chemistry
|
September 25, 2007
Synthesis of all low-energy stereoisomers of the tris(pyrrolidinoindoline) alkaloid hodgkinsine and preliminary assessment of their antinociceptive activity
Jeremy J Kodanko, Sheldon Hiebert, Emily A Peterson, et al.
Journal of the American Chemical Society
|
September 14, 2007
Total synthesis of (+)-sarain A
Michael H Becker, Peter Chua, Robert Downham, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 23, 2017
The discovery and optimization of naphthalene-linked P2-P4 Macrocycles as inhibitors of HCV NS3 protease
Michael Bowsher, Sheldon Hiebert, Rongti Li, et al.
Chemmedchem
|
July 4, 2014
4-Benzothiazole-7-hydroxyindolinyl diaryl ureas are potent P2Y1 antagonists with favorable pharmacokinetics: low clearance and small volume of distribution
Jennifer X Qiao, Tammy C Wang, Sheldon Hiebert, et al.
Journal of Medicinal Chemistry
|
October 30, 2013
Conformationally constrained ortho-anilino diaryl ureas: discovery of 1-(2-(1'-neopentylspiro[indoline-3,4'-piperidine]-1-yl)phenyl)-3-(4-(trifluoromethoxy)phenyl)urea, a potent, selective, and bioavailable P2Y1 antagonist
Jennifer X Qiao, Tammy C Wang, Réjean Ruel, et al.
Journal of Medicinal Chemistry
|
November 23, 2020
Discovery of BMS-986144, a Third-Generation, Pan-Genotype NS3/4A Protease Inhibitor for the Treatment of Hepatitis C Virus Infection
Li-Qiang Sun, Eric Mull, Stanley D'Andrea, et al.
Page
of 2